Evidence map›Paper›PMID 28077461›Full record

ArticleEMBO reports2017

Human RIF1 and protein phosphatase 1 stimulate DNA replication origin licensing but suppress origin activation.

Shin-Ichiro Hiraga, Tony Ly, Javier Garzón, Zuzana Hořejší, Yoshi-Nobu Ohkubo, Akinori Endo, Chikashi Obuse, Simon J Boulton, Angus I Lamond, Anne D Donaldson

Open access · hybridAbstract read
In one paragraph

Article in EMBO reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 149 citations in OpenAlex.

  1. Article
  2. CDC7 and APC/CNature communications · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Dynamics of Replication-Associated Protein Levels through the Cell Cycle.International journal of molecular sciences · 2024
    Article
  19. Article
  20. Review

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Shin-Ichiro HiragaInstitute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, UK s.hiraga@abdn.ac.uk a.d.donaldson@abdn.ac.uk.ORCID 0000-0002-8722-3869
Tony LyCentre for Gene Regulation & Expression, School of Life Sciences, University of Dundee, Dundee, UK.
Javier GarzónInstitute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, UK.
Zuzana HořejšíThe Francis Crick Institute, Clare Hall Laboratories, South Mimms, UK.
Yoshi-Nobu OhkuboGraduate School of Life Science, Hokkaido University, Sapporo Hokkaido, Japan.
Akinori EndoCentre for Gene Regulation & Expression, School of Life Sciences, University of Dundee, Dundee, UK.
Chikashi ObuseGraduate School of Life Science, Hokkaido University, Sapporo Hokkaido, Japan.
Simon J BoultonThe Francis Crick Institute, Clare Hall Laboratories, South Mimms, UK.
Angus I LamondCentre for Gene Regulation & Expression, School of Life Sciences, University of Dundee, Dundee, UK.ORCID 0000-0001-6204-6045
Anne D DonaldsonInstitute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, UK s.hiraga@abdn.ac.uk a.d.donaldson@abdn.ac.uk.ORCID 0000-0001-7842-8136
University of Aberdeen · GBUniversity of Dundee · GBHokkaido University · JPThe Francis Crick Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BB/K006304/1Cancer Research UK 11581Cancer Research UK 13356Cancer Research UK 19059Cancer Research UK A13356Cancer Research UK A19059Medical Research Council G0600774Wellcome TrustWellcome Trust 105024/Z/14/ZWellcome Trust 108058/Z/15/Z
6 · The paper itself

Abstract

The human RIF1 protein controls DNA replication, but the molecular mechanism is largely unknown. Here, we demonstrate that human RIF1 negatively regulates DNA replication by forming a complex with protein phosphatase 1 (PP1) that limits phosphorylation-mediated activation of the MCM replicative helicase. We identify specific residues on four MCM helicase subunits that show hyperphosphorylation upon RIF1 depletion, with the regulatory N-terminal domain of MCM4 being particularly strongly affected. In addition to this role in limiting origin activation, we discover an unexpected new role for human RIF1-PP1 in mediating efficient origin licensing. Specifically, during the G1 phase of the cell cycle, RIF1-PP1 protects the origin-binding ORC1 protein from untimely phosphorylation and consequent degradation by the proteasome. Depletion of RIF1 or inhibition of PP1 destabilizes ORC1, thereby reducing origin licensing. Consistent with reduced origin licensing, RIF1-depleted cells exhibit increased spacing between active origins. Human RIF1 therefore acts as a PP1-targeting subunit that regulates DNA replication positively by stimulating the origin licensing step, and then negatively by counteracting replication origin activation.

Indexed as

DNA ReplicationReplication OriginCell CycleCell Cycle ProteinsChromatinHumansMinichromosome Maintenance ProteinsPhosphorylationProteasome Endopeptidase ComplexProtein BindingProtein Interaction Domains and MotifsProtein Phosphatase 1Protein Serine-Threonine KinasesProteolysisTelomere-Binding ProteinsCell Cycle ProteinsChromatinMinichromosome Maintenance ProteinsProteasome Endopeptidase ComplexProtein Phosphatase 1Protein Serine-Threonine KinasesRif1 protein, humanTelomere-Binding ProteinsMCMORC1origin licensingPP1RIF1

Identifiers

PMID28077461
PMCPMC5331243
OpenAlexW2578802126

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.